87 related articles for article (PubMed ID: 6311710)
1. Missing endogenous dopaminergic inhibition of aldosterone secretion in human CONN's adenoma tissue after heterotransplantation to thymusaplastic mice.
Jungmann E; Schwedes U; Usadel KH; Obert I; Schöffling K
Horm Metab Res; 1983 Aug; 15(8):413. PubMed ID: 6311710
[No Abstract] [Full Text] [Related]
2. Human atrial natriuretic peptide (hANP) has no effect upon dopaminergic pathways: preliminary evidence in nude mice bearing heterotransplanted human CONN's adenoma tissue.
Jungmann E; Schumm-Draeger PM; Timm C; Abdelhamid S; Schöffling K
Klin Wochenschr; 1986; 64 Suppl 6():47-9. PubMed ID: 2948062
[TBL] [Abstract][Full Text] [Related]
3. Basal and ACTH-stimulated cortisol and aldosterone release from adrenocortical adenomas in vitro.
Gröndal S; Grimelius L; Thorén M; Hamberger B
Eur J Surg; 1991 Mar; 157(3):179-83. PubMed ID: 1678626
[TBL] [Abstract][Full Text] [Related]
4. [Primary dexamethasone-suppressible hyperaldosteronism and hyperprolactinemia].
Veglio F; Pinna G; Rabbia F; Mulatero P; Chiandussi L
Minerva Endocrinol; 1992; 17(1):43-6. PubMed ID: 1323053
[TBL] [Abstract][Full Text] [Related]
5. Multiple plasma steroid responses to graded ACTH infusions in patients with primary aldosteronism.
Guthrie GP
J Lab Clin Med; 1981 Sep; 98(3):364-73. PubMed ID: 6267148
[TBL] [Abstract][Full Text] [Related]
6. [Biochemical detection of Conn's adenoma: definition of criteria and reference values].
Gosse P; Guiheneuf-Tobie C; Lasserre R; Minifie C; Lemetayer P; Clementy J
Arch Mal Coeur Vaiss; 2005 Mar; 98(3):181-5. PubMed ID: 15816319
[TBL] [Abstract][Full Text] [Related]
7. [Primary normotensive hyperaldosteronism: a silent form of Conn's syndrome].
Gargallo Fernández MA; Marcos del Río N; Sola López D; Larrañaga J; Vázquez Martínez C
Rev Clin Esp; 1991 Oct; 189(5):245-6. PubMed ID: 1801074
[No Abstract] [Full Text] [Related]
8. Aldosterone-producing adenoma associated with foci of myelolipoma.
Lazurova I; Sokol L; Trejbal D; Bober J; Zachar M; Pajtasova D
Wien Klin Wochenschr; 1998 May; 110(10):379-81. PubMed ID: 9654694
[TBL] [Abstract][Full Text] [Related]
9. Dopaminergic regulation of aldosterone secretion: assessment in different subtypes of primary aldosteronism and in essential hypertension.
Veglio F; Pinna G; Rabbia F; Panarelli M; Bisbocci D; Melchio R; Chiandussi L
J Int Med Res; 1991; 19(1):44-9. PubMed ID: 1850365
[TBL] [Abstract][Full Text] [Related]
10. Adrenal vein sampling for primary aldosteronism: the assessment of selectivity and lateralization of aldosterone excess baseline and after adrenocorticotropic hormone (ACTH) stimulation.
Rossi GP; Pitter G; Bernante P; Motta R; Feltrin G; Miotto D
J Hypertens; 2008 May; 26(5):989-97. PubMed ID: 18398342
[TBL] [Abstract][Full Text] [Related]
11. Endogenous dopaminergic inhibition of aldosterone and prolactin secretion is apparently not increased in primary aldosteronism.
Jungmann E; Althoff PH; Rosak C; Schwedes U; Schöffling K
Horm Metab Res; 1986 Feb; 18(2):138-40. PubMed ID: 3699687
[TBL] [Abstract][Full Text] [Related]
12. Endocrine characterization of the adrenal adenomas in a case of primary aldosteronism.
Naruse M; Naruse K; Jibiki K; Nomura K; Demura R; Demura H; Shizume K
Tokai J Exp Clin Med; 1984 Aug; 9(3):175-82. PubMed ID: 6100405
[TBL] [Abstract][Full Text] [Related]
13. Stimulation and suppression of aldosterone secretion in patients with an aldosterone-producing adenoma.
Slaton PE; Schambelan M; Biglieri EG
J Clin Endocrinol Metab; 1969 Feb; 29(2):239-50. PubMed ID: 4303579
[No Abstract] [Full Text] [Related]
14. Response of aldosterone and 18-hydroxycorticosterone to angiotensin II in normal subjects and patients with essential hypertension, Conn's syndrome, and nontumorous hyperaldosteronism.
Fraser R; Beretta-Piccoli C; Brown JJ; Cumming AM; Lever AF; Mason PA; Morton JJ; Robertson JI
Hypertension; 1981; 3(3 Pt 2):I87-92. PubMed ID: 7262982
[TBL] [Abstract][Full Text] [Related]
15. Dynamic testing with high-dose adrenocorticotrophic hormone does not improve lateralization of aldosterone oversecretion in primary aldosteronism patients.
Rossi GP; Ganzaroli C; Miotto D; De Toni R; Palumbo G; Feltrin GP; Mantero F; Pessina AC
J Hypertens; 2006 Feb; 24(2):371-9. PubMed ID: 16508586
[TBL] [Abstract][Full Text] [Related]
16. [An observation of Conn's syndrome. Clinical and biological study].
Tourniaire J; Revol A; Maret G; Blanc-Brunat N
Rev Fr Endocrinol Clin; 1968; 9(4):333-50. PubMed ID: 4302797
[No Abstract] [Full Text] [Related]
17. [Activity of plasma renin in arterial hypertension with corticoadrenal adenoma. Conn's syndrome].
Meyer P; Ménard J; Alexandre JM; Druet P; Milliez P
Prensa Med Argent; 1966; 53(9):710-7. PubMed ID: 6003000
[No Abstract] [Full Text] [Related]
18. [Primary hyperaldosteronism-current theories].
Chodakowska J; Januszewicz W
Kardiol Pol; 1981; 24(7):519-25. PubMed ID: 7024613
[No Abstract] [Full Text] [Related]
19. [Adrenal cortex transplantation. Animal experimental models for the human Cushing and Conn syndromes--clinical aspects of adrenal cortex transplantation].
Klempa I; Schwedes U; Steinau U; Schneider M; Röttger P; Usadel KH
Chirurg; 1980 Oct; 51(10):634-43. PubMed ID: 7002496
[TBL] [Abstract][Full Text] [Related]
20. [An exemplary case of Conn's syndrome. Study of the metabolic repercussions of hyperaldosteronism and measurement of the aldosterone content in the tumor].
Linquette M; Proye C; Dupont A; Lefebvre J; Mesmacque R; Gasnault JP; Benoit G; Dessaint JP
Lille Med; 1971; 16(7):972-6. PubMed ID: 5115744
[No Abstract] [Full Text] [Related]
[Next] [New Search]
